Legend Capital

Legend Capital is a Beijing-based venture capital firm and subsidiary of Legend Holdings. Founded in 2001, it focuses on early-stage and growth investments in technology-driven sectors with operations anchored in China and related markets. The firm backs companies in IT, internet applications and services, outsourcing, IC design and key components, as well as sectors such as telecommunications, media, healthcare, consumer and intelligent manufacturing. It manages multiple funds and actively supports portfolio companies with business development, market positioning and access to Chinese markets to create value. Legend Capital aims to back high-growth ventures and build lasting value in China's venture capital ecosystem.

Daqing Cai

Managing Director

Rui Chen

Managing Director

Chen Hao

Vice Chairman

FAN Qihui

Executive Director

Ge Xinyu

Managing Director

Frank Hong

Managing Director

Henry Haiquan Ji

Executive Director

Yi Kang

Director

Jiaqing Li

Managing Director

Richard Li

President

Joon Park

Managing Director

Zhenxing Shao

Partner / Managing Director

Jenking Shao

Managing Director and Partner

Piau-Voon Wang

Managing Director

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Tony Wang

Managing Director and Vice President

William Wen

Executive Director

Hank Zhou Ph.D

Managing Director and Co-Chief Investment Officer

Quan Zhou

Managing Director, Partner

Hongbin Zhou

Managing Director

Linan Zhu

Chairman

Past deals in Series B

AiCheng Technology

Series B in 2025
Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

Volant Aerotech

Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Nuwacell

Series B in 2024
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

Macrolux Medical

Series B in 2024
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Angitia Biopharmaceuticals

Series B in 2023
Angitia Biopharmaceuticals is a global clinical-stage biotechnology company focused on discovering and developing therapeutics for musculoskeletal diseases, specifically targeting bone, muscle, and joint conditions. Through its research and development activities, it aims to deliver breakthrough therapies that address unmet needs and improve outcomes for patients with severe musculoskeletal disorders.

Saige Research

Series B in 2023
Saige Research specializes in AI solutions for industrial inspection and quality control. It offers a deep learning vision inspection platform tailored for manufacturers, enhancing inspector efficiency through power detection, speed detection, wide versatility, and convenient development.

Zhipu AI

Series B in 2023
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

Tailan New Energy

Series B in 2023
Tailan New Energy is a company co-founded by lithium battery R&D experts, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.

Open Source China

Series B in 2023
Open Source China is a prominent online community focused on open source software technology. It serves as a platform for IT developers to discover, utilize, and exchange open source technologies, facilitating collaboration and innovation within the field. The community offers a variety of resources, including open source software libraries, code sharing, discussion forums, collaborative translation, and blogs. Additionally, Open Source China provides support through technical questions and answers, as well as software information services, creating an environment conducive to the development and optimization of open source technologies for domestic developers.

DentaFilm

Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

Rongke Power

Series B in 2023
Rongke Power specializes in the development and manufacturing of vanadium redox flow batteries, focusing on safe and reliable energy storage solutions. The company offers a diverse range of products, including its VPower, TPower, and UPowertm lines, as well as container energy storage systems and comprehensive energy storage solutions. Rongke Power provides operation and maintenance services for power stations, empowering enterprises to create cleaner and more energy-efficient energy grids. With a commitment to independent intellectual property rights, the company positions itself as a key player in the energy storage industry.

Shuhai Supply Chain

Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

APTBIO

Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

RUICYCLE

Series B in 2022
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company develops innovative solutions for the recovery and regeneration of lithium battery materials, emphasizing cascade utilization and new material recycling. RUICYCLE's technologies enable an industrial ecological closed loop that ensures automatic, safe crushing of batteries, alongside zero pollution treatment and recycling solutions. Through its advanced methodologies, RUICYCLE aims to address the growing challenges associated with lithium battery waste and promote sustainability in the battery industry.

Joymed Technology

Series B in 2022
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

ZHIYI TECH

Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.

MediLink Therapeutics

Series B in 2022
MediLink Therapeutics is a China-based developer of antibody-drug conjugates (ADC) focused on cancer therapy. The company advances next-generation ADCs and aims to address unmet medical needs in China, while pursuing global value through multicenter clinical trials and cross-border collaborations. Its R&D center is in Suzhou.

Inceptio Technology

Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Zhipu AI

Series B in 2022
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Singlomics

Series B in 2022
Singlomics is a biotechnology company that leverages single-cell sequencing technology to develop innovative antibody drugs aimed at treating infectious diseases and cancers. The company focuses on the discovery and development of neutralizing antibodies, including DXP593 and DXP604, which serve as potential therapeutic solutions against COVID-19. By utilizing advanced sequencing techniques, Singlomics aims to enhance the efficacy of antibody treatments and address significant health challenges in infectious diseases and oncology.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Xbiome

Series B in 2021
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

LePure Biotech

Series B in 2021
LePure Biotech, established in 2011 and headquartered in Shanghai, China, operates within the biotechnology and pharmaceutical sectors. The company specializes in the development and manufacturing of disposable biopharmaceutical process equipment and consumables, primarily focusing on products that facilitate the storage, transportation, filling, and leak detection of samples related to biosimilars, vaccines, and other biopharmaceutical applications. Its core offering is a disposable storage bag designed to meet the specific needs of these processes. Recently, LePure Biotech completed a B+ round of financing, which aims to fund the development of innovative products, establish a research and development center in the United States, enhance supply chain integration, and expand its R&D operations both domestically and internationally.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, founded in 2009. The company specializes in providing research and development services to facilitate drug discovery. Its offerings include recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus operates five advanced research platforms, including X-ray crystallography and cryo-electron microscopy, aimed at delivering high-quality R&D services to clients. The organization is known for its innovative approaches, with several techniques developed by its research team receiving patents. Wuxi Biortus is a subsidiary of Jiangsu Shuangliang Group Company Ltd.

ForQaly

Series B in 2021
ForQaly is a medical device company specializing in the development of minimally invasive ventricular assist devices aimed at treating heart failure. The company focuses on creating therapeutic solutions that enhance circulation for patients, ensuring affordability and ease of use for healthcare providers. By prioritizing small trauma and large auxiliary flow in its designs, ForQaly's products are intended to offer effective and accessible care for individuals suffering from heart-related conditions, ultimately improving patient outcomes and quality of life.

HC Scientific

Series B in 2021
HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

YEASEN Biotechnology

Series B in 2021
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.

Bloks Technology Group

Series B in 2021
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bloks Group strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Dearer Medical

Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

Fiture Technology

Series B in 2021
Fiture is a fitness technology company focused on transforming home fitness experiences through intelligent hardware and AI-driven content. The company offers customized online workout programs and manufactures advanced home workout equipment, utilizing artificial intelligence to enhance user engagement and effectiveness. By prioritizing the development of innovative solutions, Fiture aims to support clients in achieving their health and fitness goals from the comfort of their homes.

Stonewise

Series B in 2021
StoneWise is a technology company established in 2018 that focuses on accelerating novel drug discovery through the application of artificial intelligence. The company aims to revolutionize the traditional drug research and development process by introducing a dual-engine model that combines advanced AI technology with expert systems. Its platform incorporates cutting-edge technologies, including artificial intelligence and microfluidics, and integrates various fields such as computational chemistry, computational biology, pharmacology, and clinical medicine. StoneWise offers a comprehensive suite of services, including medical knowledge graphs, molecular generation and design, and predictions of reaction products, all designed to enhance the efficiency and success rates of early-stage drug discovery. The company collaborates with both domestic and international academic institutions, research organizations, and pharmaceutical manufacturers, and it is equipped with a state-of-the-art scientific facility to support its innovative initiatives in drug discovery.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company that focuses on the development and commercialization of protein and peptide-based drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company targets multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neurodegenerative disorders. Sciwind's innovative drug candidates are particularly designed to address metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for physicians and their patients.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Jinqirui Biology

Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Xbiome

Series B in 2020
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

Aqrose Technology

Series B in 2020
Aqrose Technology Co., Ltd., established in 2017 and originating from the AI Lab of Tsinghua University, specializes in integrating advanced artificial intelligence and machine vision technologies into industrial applications. The company develops products such as AIDI, a standardized intelligent industrial vision platform, and AIPICK, an intelligent inspecting and sorting robot that utilizes 3D vision technology. Aqrose's solutions are designed to enhance manufacturing processes and product quality across various sectors, including consumer electronics, automobiles, new energy, medicine, semiconductors, and logistics. Their innovations have been implemented in over 100 factories, serving prominent clients in advanced manufacturing and smart logistics, thereby contributing to increased efficiency and effectiveness in these industries.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

HEMO BIOENGINEERING

Series B in 2020
HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

Leadrive

Series B in 2020
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

HaiHe Biopharma

Series B in 2020
HaiHe Biopharma is a biotechnology company focused on developing innovative anti-tumor drugs to address complex diseases and advance pharmacological evaluation. It engages in discovery, development, and commercialization of anti-tumor therapies, conducts pharmacological efficacy evaluation, and offers products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, helping customers improve health outcomes and research quality.

ESWIN Computing

Series B in 2020
ESWIN Computing is a technology company focused on the research, development, and design of IoT chips and RISC-V computing architectures. It develops chips and related components for display devices and wearable devices, emphasizing the design, testing, and materials of IoT and human-computer interaction integrated circuits. The company provides chips used in artificial intelligence, Internet of Vehicles, displays, and wearable technologies, supporting applications across consumer electronics and smart devices.

Uditech

Series B in 2020
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

iBeiDiao

Series B in 2020
iBeiDiao offers intelligent employee background investigation services. It uses AI to provide objective checks and streamline onboarding processes, delivering reliable credit reference data to help businesses make informed hiring decisions.

Wangdiantong

Series B in 2020
Wangdiantong is a provider of enterprise-level e-commerce solutions, specializing in retail cloud services that facilitate the digital transformation of businesses. The company offers a comprehensive ERP system that integrates with major online platforms such as Taobao, Tmall, and Amazon, among others. Its solutions encompass a wide range of functionalities, including inventory management, order processing, purchasing, after-sales support, accounts management, and customer relationship management (CRM). Additionally, Wangdiantong supports multi-warehouse operations and provides tools for managing both online and physical store cashiers. By leveraging intelligent warehouse and ERP solutions, the company aims to help businesses scale and achieve efficient, intelligent management practices in an increasingly digital marketplace.

Healing Paper

Series B in 2020
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

ANYCOLOR

Post in 2020
ANYCOLOR is a start-up in the entertainment industry, specializing in supporting and managing virtual talent, notably the Nijisanji Project. They facilitate the operation of virtual talents, known as "virtual rivers," within this project. The company leverages advanced technology to create innovative experiences for global audiences, aiming to enrich everyday lives through its unique offerings.

Harbour BioMed

Series B in 2020
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Genskey

Series B in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Nanovision

Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base, specializes in high-speed and high-precision radiology imaging solutions. With a significant research and development presence in Yonyou Industrial Park and a subsidiary in Chengdu, the company focuses on static computed tomography (CT), X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision developed China's first self-designed CMOS flat panel detector, known as the Merak series, which serves a diverse range of applications across medical, industrial, and security sectors. By providing advanced technological support both domestically and internationally, Nanovision aims to enhance imaging capabilities in various fields.

RT-Thread

Series B in 2019
RT-Thread is a Shanghai-based company founded in 2006 that specializes in developing an open-source real-time operating system (RTOS) designed for embedded devices. The RT-Thread operating system supports a range of features suitable for the Internet of Things (IoT), including cross-chip platform compatibility, real-time kernel capabilities, cloud integration, and ultra-low power design. The system is available in two versions: a Standard version for resource-rich IoT devices, and a Nano version tailored for resource-constrained microcontroller systems, requiring minimal memory resources. RT-Thread employs object-oriented programming techniques to ensure that its code is elegant, modular, and easily customizable. Its offerings include a suite of functionalities such as a device virtual file system, device management framework, low-power management, and support for firmware remote upgrades. The company serves various industries, including new energy, home appliances, and transportation, facilitating seamless connectivity and operational efficiency across IoT applications.

Xbiome

Series B in 2019
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd is a prominent manufacturer of pet food, specializing in a diverse array of products including dry and wet food, real meat jerky treats, rawhide chews, and dental bones. Founded in 2006 and headquartered in Liaocheng City, China, the company focuses on the research, development, production, and sales of various pet food categories. Its offerings encompass pet treats made from chicken, duck, pork, lamb, and fish, as well as dog food enriched with nutritional supplements and natural ingredients. Gambol Pet Group serves a wide customer base across Europe, Asia, and North America, demonstrating its international reach and commitment to quality in pet nutrition. The company is led by Chairman and CEO Qin Hua.

dMed

Series B in 2019
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

QANDA(Mathpresso)

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

GalaxySpace

Series B in 2019
Founded in 2016, GalaxySpace specializes in developing and manufacturing low Earth orbit (LEO) broadband satellite constellations for global internet connectivity. Their satellite applications include monitoring services for airports, parking lots, oil reserves, and land use assessment.

AgotoZ

Series B in 2019
AgotoZ Technology, established in 2017, specializes in high-speed network transmission solutions for enterprises. The company, operating under Guanmai Technology (Beijing) Co., Ltd., focuses on developing advanced technologies in WAN transmission, big data computing, and security defense. AgotoZ aims to enhance enterprise performance by providing an efficient interoperability platform and related solutions, ensuring that businesses can effectively meet their network transmission needs. Through independent research and development, AgotoZ continues to innovate its core technologies and products, positioning itself as a leader in the field of intelligent network transmission.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Inossem is a Montreal-based technology company that specializes in supporting organizational digital transformations. It offers R&D and consulting services for enterprise applications, focusing on three key areas: corporate advisory services, digital supply chain, and digital workforce. Inossem's enterprise consulting services encompass IT planning, supply chain consulting, ERP consulting, among others. Its digital supply chain products include intelligent storage (InStock) and master data management (InData), along with supply chain optimization tools like InoVAT for improved warehouse and inventory management. For the digital workforce, Inossem provides process automation tools such as ProcessGo to facilitate rapid data integration and process automation. The company's IoT and AI research labs drive innovation in these areas, serving clients across Canada.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

Jiangrongxin Technology

Series B in 2019
Jiangrongxin Technology is a developer of financial and marketing software tailored for consumer financial services enterprises. The company specializes in creating a credit card core system that assists card issuers in managing cardholders' credit and incentive programs effectively. Additionally, Jiangrongxin Technology offers a marketing platform designed to provide purchase recommendations to consumers and monitor user retention. Through these solutions, the company aims to enhance the operational efficiency of financial service providers and improve customer engagement.

River Security

Series B in 2019
River Security is a cybersecurity company that specializes in fraud risk protection and innovative dynamic application security solutions. Founded in 2012 and headquartered in Shanghai, with additional offices in Beijing and Shenzhen, the company has developed cutting-edge active defense security technology after extensive research and development. This technology challenges traditional security paradigms that have been in place for over two decades, enabling more effective and timely defenses against a wide range of modern cyber threats. River Security's products include a dynamic security bot-gate that predicts server behavior by transforming the underlying code of web pages, thereby enhancing the protection of corporate website applications and safeguarding business data. The company's approach not only improves security measures but also reduces deployment and operational costs for users.

Black Sesame Technologies

Series B in 2019
Founded in 2016 with headquarters in Silicon Valley and Shanghai, Black Sesame Technologies specializes in AI digital imaging technology. It develops image/video processing algorithms and related applications for various imaging systems, focusing on embedded sensing platforms for smartphones, autonomous driving, and consumer electronics.

Likechuxing

Series B in 2019
Likechuxing is a car-sharing travel service platform designed for urban travelers, leveraging the sharing economy to transform traditional car travel. By integrating mobile Internet technology with a time-sharing model, the platform allows users to conveniently access vehicles located within 500 meters. This innovative approach caters specifically to the needs of short-haul travel within cities, enabling users to manage their car rental experience through a mobile app. The app facilitates intelligent operation throughout the entire process, allowing users to pay only for the mileage and long-term costs associated with their journeys. Likechuxing effectively redefines the car rental experience, making urban mobility more efficient and accessible.

Tenry Pharmaceutical

Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited (Tenry) is a modern pharmaceutical enterprise based in Shanghai, specializing in the development and production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company operates two advanced manufacturing plants and has achieved approval for 73 national drugs, including two biological agents. Tenry's primary focus includes research and development, sales and marketing, and regulatory compliance, allowing it to provide innovative treatments for patients. Its leading products address critical needs in bleeding management and wound management, positioning Tenry as a significant player in the pharmaceutical industry.

Harbour BioMed

Series B in 2018
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Urotronic

Series B in 2018
Urotronic Inc., established in 2014 and headquartered in Plymouth, Minnesota, specializes in developing and manufacturing medical devices for urological applications. The company's primary product is Optilume, a Drug Coated Balloon (DCB) catheter designed to treat urethral strictures in men by dilating the blocked area and delivering a drug that prevents scar tissue formation. This minimally invasive procedure reduces patient discomfort and recovery time compared to traditional surgical methods. Urotronic serves both urologists and patients, aiming to improve treatment outcomes for urinary tract conditions.

Spacety

Series B in 2018
Spacety, established in 2016 and headquartered in Changsha, China, is a microsatellite company specializing in developing and launching commercial micro and nano-satellites. It offers rapid, cost-effective, and comprehensive services to scientists, research institutions, and businesses for scientific experiments and technology demonstrations. As of now, Spacety has successfully launched four commercial microsatellites, with plans for more in the future.

Lunit

Series B in 2018
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Aikucun

Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.

Renderbus

Series B in 2018
Renderbus provides vertical cloud computing SaaS services for the vision industry.

Paixue Che

Series B in 2018
Pai Xueche is an Internet driving training platform. The school adopts a consultant tracking system throughout the process. The company will equip each student with an exclusive learning car consultant, from registration to the student's driver's license, the whole process of tracking.

Enjoy Dental Clinic

Series B in 2018
Enjoy Dental Clinic is a prominent dental care provider established in 2007 and headquartered in Beijing, China. This large-scale dental chain integrates medical treatment with scientific research, education, and administrative functions. The clinic is committed to standardized practices for oral safety, utilizing a four-hand operation model and a rigorous "one person, one machine" aseptic disinfection protocol. Enjoy Dental Clinic employs advanced technologies, including 3D printing, digital-guided dental implants, ultra-thin cosmetic dentistry, and oral digital CT scanning, which enhance treatment efficacy and patient satisfaction. Additionally, the clinic offers franchising services, providing aspiring dentists with professional training and practical experience in clinic management.

Nattitude

Series B in 2018
Nattitude is a retailer specializing in consumer personal care products, particularly in the amino acid cosmetics sector. The company develops and sells a range of products including amino acid shampoos, cleansing mousse, and shower gels, with a focus on providing high-quality and affordable options for Chinese families. Through its subscription personal care brands, such as Zhiguan, Nattitude aims to deliver healthy and natural personal care solutions to its customers. The company has attracted venture capital investments, reflecting its growth and potential in the evolving market of personal care products in China.

Uditech

Series B in 2018
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

DeepWise

Series B in 2018
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

INXX

Series B in 2018
INXX is an online retail platform that specializes in fashionable clothing, catering to fashion leaders, artists, and designers. The company focuses on high-end professional sportswear and aims to create a vibrant hub for streetwear culture in China. By bringing together local and international fashion brands, INXX provides consumers with access to a diverse range of high-quality fashion products. This platform not only promotes streetwear culture but also fosters collaboration among artists, designers, and art toy creators from various fields, establishing a trendy area for fashion enthusiasts. Through its innovative approach, INXX enhances the shopping experience by efficiently connecting clients with sought-after fashion goods.

Kunya Medical

Series B in 2018
Kunya Medical is a provider of medical equipment management services, specializing in the maintenance, installation, and repair of hospital medical equipment. The company offers comprehensive outsourcing solutions that enhance the efficiency of medical equipment management within hospitals, thereby extending the lifecycle of critical clinical devices. Kunya Medical caters to both domestic and international brands of large and medium-sized medical equipment, delivering services such as technical maintenance, equipment relocation, installation, and debugging. Additionally, the company supplies a full range of spare parts and equipment management software, ensuring that hospitals can effectively manage their medical assets.

iPayLinks

Series B in 2018
iPayLinks is a prominent provider of cross-border settlement services based in Lujiazui, Shanghai, with branches in several key international markets, including Hong Kong, Singapore, the UK, and the US. The company offers a comprehensive "three-in-one" one-stop solution tailored for cross-border e-commerce and travel, facilitating transactions through various international credit and debit cards, as well as localized payment methods across over 200 regions. iPayLinks supports collection services from major platforms like Amazon and eBay, and has developed an integrated collection and distribution system. Additionally, the company provides supply chain finance products that assist businesses in optimizing their working capital. iPayLinks is distinguished by its attainment of numerous international licenses and holds the PCI-DSS Level-1 certification, underscoring its commitment to security in the payment services industry. The company has garnered recognition through multiple awards and has attracted significant investment from notable investors, establishing itself as a leader in the cross-border payment sector.

Hongliyu Cinema

Series B in 2018
Hongliyu Cinema is a Chinese rural cinema operator that specializes in managing and operating a network of local cinemas. The company provides comprehensive cinema management and operation services, with a strong emphasis on theater investment and professional training. In addition to its operational focus, Hongliyu Cinema engages in film and television production, as well as advertising services. Its mission is to enhance the efficiency of theater operations and improve digital media services, ultimately contributing to the growth and development of cinema in rural areas of China.

Taihe Music Group

Series B in 2017
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.

Yanwen Express

Series B in 2017
Beijing Yanwen Logistics Co., Ltd, established in 1998 and headquartered in Beijing, China, is a specialized logistics company providing freight forwarding and logistics services. The company focuses on serving e-commerce businesses by offering tailored international logistics solutions. Yanwen is equipped to handle a wide range of shipments, from small packages to larger goods, utilizing various modes of transportation including aircraft, trains, and automobiles. The firm emphasizes professional transport management to meet the diverse needs of its customers, supported by approvals from relevant government departments.

Immunochina

Series B in 2017
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

WeShine

Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.

Qian Qian Music

Series B in 2017
Qian Qian Music is an online music platform.

Vingoo Juice

Series B in 2017
Vingoo Juice is a company that specializes in creating innovative, autonomous machines for producing fresh orange juice, primarily targeting the community market in China. These machines employ a whole fruit extraction method, which maximizes juice yield from each orange, ensuring customers receive enhanced value for their purchases. By integrating advanced technologies such as cloud computing, artificial intelligence, and mobile payment systems, Vingoo Juice significantly enhances the consumer experience, making the process of obtaining fresh juice more convenient and efficient.

Bellen

Series B in 2017
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent track records, as we deliver unrivalled chemical innovation to our customers worldwide.

Ucpaas

Series B in 2017
Shenzhen City Network Technology Co., Ltd., commonly known as Ucpaas, specializes in providing a cloud communication platform that facilitates converged communication services for developers and businesses. The company offers an open-source platform that integrates various communication capabilities, including voice, SMS, VoIP, video conferencing, and identity verification, through accessible APIs and SDKs for multiple operating systems. With over a decade of experience in the VoIP communications industry, Ucpaas has amassed a substantial user base, serving more than 200 million registered users and capturing over 70 percent of telecommunications resources in the sector. The company is driven by a team of professionals with extensive backgrounds in telecommunications and IT, allowing for strong innovation and operational expertise. Ucpaas aims to streamline business communication processes, enabling users to efficiently manage their communication needs without the burden of hardware or high network costs.

New Horizon Health

Series B in 2017
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.

Akulaku

Series B in 2017
Akulaku is a Southeast Asia fintech platform that provides online credit and digital financial services. Founded in 2016 and based in Jakarta, Indonesia, it serves customers across Indonesia, the Philippines, and Malaysia with digital banking, digital financing, digital investment, and insurance brokerage offerings. The company operates a virtual credit card and ecommerce platform, as well as Asetku, an online wealth management service, and a mobile neobank supported by Bank Neo Commerce. It focuses on meeting the daily financial needs of underserved customers in emerging markets and aims to reach about 50 million users across Southeast Asia by 2025.

PhiSkin

Series B in 2017
PhiSkin is a skin and laser clinic based in China that specializes in aesthetic medicine. The company offers a range of services including aesthetic product injections, such as Botox and hyaluronic acid, laser treatments, double eyelid surgery, and various non-surgical beauty procedures. PhiSkin aims to provide customers with a thorough understanding of their skin conditions while delivering tailored skincare solutions to meet individual needs.

Bangsun Technology

Series B in 2017
Bangsun Technology, based in Hangzhou, China, specializes in developing online payment security software tailored for domestic internet trading companies and financial institutions. Founded in 2010, the company offers a range of solutions, including banking and tripartite payment solutions, as well as services for bank cards, credit cards, and securities. Its product lineup features real-time transaction anti-fraud systems, Internet credit services, data analytics through machine learning, device fingerprinting, and anti-money laundering solutions. Additionally, Bangsun Technology focuses on providing comprehensive risk management services, including application anti-fraud measures and robot defense, to enhance the security of financial transactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.